Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Healthcare Reform Outlook for Rest of 2014 and 2015
At the 1st Chinese Hospital Authority Symposium, which is sponsored by the China Hospital Association, LIANG Wanniang, Director General of NHFPC's System Reform Departmen... (10/20/2014)
   
Success Story: CleveXel's Collaboration with Guilin Pharma for Development of Artesunate Injection (10/8/2014)
China Continues to Push Healthcare Reform with More Liberal Policies (9/26/2014)
Three Take-Home Messages from China's Glaxo Verdict (External) (9/25/2014)
Lessons from GlaxoSmithKline's Record $492 Million Bribery Fine in China (External) (9/24/2014)
China Just Gave Foreign Pharmacy Retailers A Big Green Light (External) (9/24/2014)
How Should Foreign Companies Interpret GSK's China Fines And Penalties? (External) (9/23/2014)
Legislative Reform of China's Healthcare Sector Targets Corruption: Implications for MNCs (External) (9/12/2014)
Chinese Healthcare Reforms May Be A Double-edged Sword for Foreign Companies (External) (9/12/2014)
China's Unequal Health Coverage System (External) (9/12/2014)
The Lancet: Diabetes in China: Mapping the Road Ahead (External) (9/10/2014)
China's Pursuit of a Domestic Life Science Sector (External) (8/29/2014)
A Short-Term Conviction Leaves Big Long-Term Questions Unanswered (8/28/2014)
ZS: The Secret to Reducing the Impact of Turnover Is Hidden in Plain Sight (8/27/2014)
ZS: Are You Ready for the Lower Tier Market? (8/27/2014)
Chinese Pharma R&D Marks Step Forward (External) (8/25/2014)
NHFPC Ministers Strikes Multiple Health ...  (10/20/2014) (free)
CFDA Expected to Issue Internet Drug Sal...  (10/20/2014)
WFP Criticizes China as the Country and ...  (10/20/2014) (free)
Financial-related Company News in Brief  (10/20/2014)
Healthcare Reform Outlook for Rest of 20...  (10/20/2014)
J&J to Move Asia Pacific R&D...  (10/20/2014)
Recent Executive Moves  (10/20/2014)
China Biologic Approved for Production o...  (10/17/2014) (free)
Infectious Disease on the Rise Again in ...  (10/17/2014)
Recent Executive Moves  (10/17/2014)
CFDA to Reform Drug Registration Applica...  (10/17/2014)
Beijing Launches New Healthcare Reform F...  (10/17/2014)
80% of Listed Chinese Pharma Companies I...  (10/17/2014)
NDRC Responds to Price Regulator Probes  (10/16/2014)
Upcoming Event: Executive Etiquette Exce...  (10/15/2014) (free)
Bayer to Focus Entirely on Life Science Businesses
GSK May Spin Off Its Consumer Healthcare Division
Abbvie to Acquire Shire for US$55 Billion
Survey: Smartphones Preferred Healthcare Communication C...
Shire Rejects Takeover Offer from Abbvie
China's Western Medicine Foreign Trade Maintains Steady Growth ...
IMS: Chinese Hospital Drug Sales Growth Slowed in Q1/2014
Chinese Vaccine Market Still Dominated by State-owned Companies...
Data Snapshot - Chinese Pharma Growth Dropped Sharply in July
Review of China's Pharmaceutical Formulation Foreign Trade in H...
Financial-related Company News in Brief
J&J to Move Asia Pacific R&D Center to Shanghai ...
China Biologic Approved for Production of Human Prothrombin ...
80% of Listed Chinese Pharma Companies Issue Positive Earnin...
IMF Sublicenses Rotavirus Vaccine to China-based BravoVax
CFDA Expected to Issue Internet Drug Sales Regulation Ea...
CFDA to Reform Drug Registration Application Process for...
NDRC Responds to Price Regulator Probes
Chinese Media Challenges the CMA over Sponsorships
CFDA Issues Notice Over Distribution of Vaccines at the ...
Chinese Court Imposes CNY 3 Bln Record Fine on GSK for Bribe...
US Anti-bribery Probe Expands to GSK Consumer Healthcare Bus...
Chinese Advertisement Law Amendment to Heighten Requirements...
CFDA Officials Sued and Accused of Dereliction over Vaccine ...
GSK-linked Investigators Do Not Want to Appeal Their Sentenc...
Chinese API Import Volume Grew 15.56% in the First Half
WuXiPharmaTech's API Subsidiary Passed USFDA Inspection
Study: India Heavily Dependent on China for Essential AP...
FDA Issues Warning Letter to Tianjin Zhongan Pharmaceuti...
Snapshot Review of the Chinese Vitamins Industry – Oppo...
Sihuan Buys Rights of Ebola Drug from AMMS UNIT
"Virological Penicillin" Found in Chinese Herbal Medicin...
Biostar Files Chinese Patent Application for HBV and Liv...
Sino-French Research Team Finds Potential HIV Vaccine
Research Team under SIMM Discovers Lead Compound to Pote...
NHFPC Ministers Strikes Multiple Health Cooperation Pact...
WFP Criticizes China as the Country and France Boost Ebo...
Healthcare Reform Outlook for Rest of 2014 and 2015
Infectious Disease on the Rise Again in China
Beijing Launches New Healthcare Reform Framework Policy
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Three More Senior NDRC Price Regulators Taken Away for Inv...
Upcoming Event: Executive Etiquette Excellence Seminar b...
NHFPC Vice Minister Meets Senior UCB Delegation
Upcoming Event: ChinaTrials 7
China and India Enter Trade Pact with Pharma Issues Addr...
EU and U.S. Warns China Over Anti-Monopoly Efforts
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links